Scientific article

Effects of Antidiabetic Drugs on Gut Microbiota Composition

Published inGenes, vol. 8, no. 10
Publication date2017

Gut microbiota forms a catalog of about 1000 bacterial species; which mainly belong to the Firmicutes and Bacteroidetes phyla. Microbial genes are essential for key metabolic processes; such as the biosynthesis of short-chain fatty acids (SCFA); amino acids; bile acids or vitamins. It is becoming clear that gut microbiota is playing a prevalent role in pathologies such as metabolic syndrome; type 2 diabetes (T2D); inflammatory and bowel diseases. Obesity and related diseases; notably type 2 diabetes, induce gut dysbiosis. In this review; we aim to cover the current knowledge about the effects of antidiabetic drugs on gut microbiota diversity and composition as well as the potential beneficial effects mediated by specific taxa. Metformin is the first-line treatment against T2D. In addition to its glucose-lowering and insulin sensitizing effects, metformin promotes SCFA-producing and mucin-degrading bacteria. Other antidiabetic drugs discussed in this review show positive effects on dysbiosis; but without any consensus specifically regarding the Firmicutes to Bacteroidetes ratio. Thus, beneficial effects might be mediated by specific taxa.

Citation (ISO format)
MONTANDON, Sophie, JORNAYVAZ, François. Effects of Antidiabetic Drugs on Gut Microbiota Composition. In: Genes, 2017, vol. 8, n° 10. doi: 10.3390/genes8100250
Main files (1)
Article (Published version)
ISSN of the journal1462-6438

Technical informations

Creation12/15/2017 11:25:00 AM
First validation12/15/2017 11:25:00 AM
Update time03/30/2023 10:51:13 AM
Status update03/30/2023 10:51:13 AM
Last indexation01/17/2024 1:51:39 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack